by Ashley | Jul 22, 2020 | COVID-19, Press Release
Personalized Stem Cells, Inc. (PSC) has received FDA approval for an Investigational New Drug (IND) application for the treatment of COVID-19 patients with stem cells. The first trial is named “CoronaStem 1” and will provide treatment for 20 hospitalized COVID-19...
by Ashley | Jul 15, 2020 | Press Release
San Diego based regenerative medicine company, Personalized Stem Cells, Inc. (PSC), has secured $2.5 million in a Series A round of financing led by seed investors and key opinion leaders in the field. The funds will enable PSC to complete the current FDA approved...
by Ashley | May 1, 2020 | Blog, COVID-19
On April 27, 2020 PSC CEO, Dr. Bob Harman and PSC Medical Director, Dr. Christopher Rogers, were interviewed by San Diego CBS affiliate, KFMB TV. The interview provides an excellent overview of how Personalized Stem Cells is working with the FDA and the White House...
